
    
      This will be a multi-center, double-blind, placebo controlled, parallel, 12 week treatment
      trial in men with signs and symptoms of benign prostatic hyperplasia and nocturia. The
      following procedures are utilized; physical exams, electrocardiograms, clinical laboratory
      tests, vital signs, urinary diary, Pittsburgh Quality of Sleep Index, Nocturia Quality of
      Life
    
  